Investment thesis
Titian Capital is a private family office based in Abu Dhabi with interests across life sciences, artificial intelligence, digital advertising and infrastructure. It invests through group companies, including a life sciences platform trading as Titian Life Sciences, and is led by managing director Kayaan Unwalla. In October 2025 it acquired a significant interest in Cellcolabs, the Stockholm stem cell manufacturer, in a round reported at USD 12 million.
Past investments
| Company | Round | Date | Round size |
|---|---|---|---|
| Cellcolabs Sweden | - | Oct 2025 | €10.3M |